Mechanism and treatment of dropped head syndrome associated with parkinsonism

Parkinsonism and Related Disorders

Volumn 15, Issue 3, 2009, Pages 181-186

  Oyama, Genko ^a   Hayashi, Akito ^a   Mizuno, Yoshikuni ^a   Hattori, Nobutaka ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Botulinum toxin; Dropped head syndrome (DHS); Lidocaine; Muscle afferent block; Parkinsonism

Indexed keywords

ALCOHOL; BOTULINUM TOXIN A; CABERGOLINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; LIDOCAINE; PERGOLIDE; PRAMIPEXOLE; SULPIRIDE;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DROPPED HEAD SYNDROME; DRUG RESPONSE; ELECTROMYOGRAM; FEMALE; HUMAN; MALE; MUSCLE WEAKNESS; NECK MUSCLE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; STERNOCLEIDOMASTOID MUSCLE;

AGED; AGED, 80 AND OVER; ANESTHETICS, LOCAL; BOTULINUM TOXINS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOPAMINE AGENTS; DRUG THERAPY, COMBINATION; ELECTROMYOGRAPHY; ETHANOL; FEMALE; HEAD MOVEMENTS; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; MOVEMENT DISORDERS; NECK MUSCLES; PARKINSONIAN DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 60549092530     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2008.04.040     Document Type: Article

References (12)

1. Suarez G.A., and Kelly J.J. The dropped head syndrome. Neurology 42 (1992) 1625-1627
2. Qinn N. Disproportionate antecollis in multiple system atrophy. Lancet 1 (1989) 844
3. Umapathi T., Chaudhry V., Cornblath D., Drachman D., Griffin J., and Kuncl R. Head drop and camptocormia. J Neurol Neurosurg Pyschiatry 73 (2002) 1-7
4. Kaji R., Kohara N., Katayama M., Kubori T., Mezaki T., Shibasaki H., et al. Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp. Muscle Nerve 18 (1995) 234-236
5. Kashihara K., Ohno M., and Tomita S. Dropped head syndrome in Parkinson's disease. Mov Disord 21 (2006) 1213-1216
6. Sato K., Hatano T., Yamashiro K., Kagohashi M., Nishioka K., Izawa N., et al. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 21 (2006) 1384-1395
7. Ogawa N. Early introduction of dopamine agonists in the long-term treatment of Parkinson's disease. Neurology 51 S2 (1988) S13-S18
8. Askmark H., Eeg-Olofsson K.E., Johansson A., Nilsson P., Olsson Y., and Aquilonius S.M. Parkinsonism and neck extensor myopathy: a new syndrome or coincidental findings?. Arch Neurol 58 (2001) 232-237
9. Mayoux-Benhamou M.A., Revel M., and Vallee C. Selective electromyography of dorsal neck muscles in humans. Exp Brain Res 113 (1997) 353-360
10. Conley M.S., Meyer R.A., Bloomberg J.J., Feeback D.L., and Dudley G.A. Noninvasive analysis of human neck muscle function. Spine 20 (1995) 2205-2212
11. Ishii A., Hayashi A., Inoue C., Shoji S., and Tachikawa H. Intramuscular injection of lidocaine and ethanol in patients with spasmodic torticollis: muscle afferent block therapy: clinical evaluation and experimental study of muscular histology. JMDD 6 (1996) 89-95
12. Yoshiyama Y., Takama J., and Hattori T. The DHS sign in parkinsonism. J Neurol Sci 167 (1999) 22-27